OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Jin Zhou, Madhulika Tripathi, Rohit A. Sinha, et al.
Hepatoma Research (2021) Vol. 2021
Open Access | Times Cited: 38
Jin Zhou, Madhulika Tripathi, Rohit A. Sinha, et al.
Hepatoma Research (2021) Vol. 2021
Open Access | Times Cited: 38
Showing 26-50 of 38 citing articles:
Molecular mechanisms of liver carcinogenesis related to metabolic syndrome
Claudia Campani, Jean‐Charles Nault
Hepatoma Research (2022)
Open Access | Times Cited: 6
Claudia Campani, Jean‐Charles Nault
Hepatoma Research (2022)
Open Access | Times Cited: 6
Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances
Hao Qin, Baowen Yuan, Wei Huang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Hao Qin, Baowen Yuan, Wei Huang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
HIV Pre-exposure Prophylaxis and Its Impact on the Gut Microbiome in Men Having Sex With Men
Nicola Luigi Bragazzi, Rola Khamisy‐Farah, Christina Tsigalou, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 4
Nicola Luigi Bragazzi, Rola Khamisy‐Farah, Christina Tsigalou, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 4
Emerging computational paradigms to address the complex role of gut microbial metabolism in cardiovascular diseases
Javad Aminian-Dehkordi, Amin Valiei, Mohammad R. K. Mofrad
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Javad Aminian-Dehkordi, Amin Valiei, Mohammad R. K. Mofrad
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
Yuan Yao, Yunfeng Shen
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Yuan Yao, Yunfeng Shen
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Emerging Therapies for Non-Alcoholic Steatohepatitis (NASH): A Comprehensive Review of Pharmacological and Non-Pharmacological Approaches
Shradha P Kakde, Maham Mushtaq, Maryyam Liaqat, et al.
Cureus (2024)
Open Access
Shradha P Kakde, Maham Mushtaq, Maryyam Liaqat, et al.
Cureus (2024)
Open Access
The role of gut microbiome and fecal microbiota transplantation in liver cancer and related complications: mechanisms and therapeutic potentials
Min Dai, Rashid N. Lui, Louis Ho Shing Lau
Hepatoma Research (2023)
Open Access | Times Cited: 1
Min Dai, Rashid N. Lui, Louis Ho Shing Lau
Hepatoma Research (2023)
Open Access | Times Cited: 1
Effect of Probiotic Supplementation on Sprague Dawley Rat Liver Histopathology Fed by High Fat High Fructose Diet
Ninung Rose Diana Kusumawati, Damianus Galih Panunggal, Maria Mexitalia, et al.
Journal of Biomedicine and Translational Research (2021) Vol. 7, Iss. 2, pp. 69-73
Open Access | Times Cited: 1
Ninung Rose Diana Kusumawati, Damianus Galih Panunggal, Maria Mexitalia, et al.
Journal of Biomedicine and Translational Research (2021) Vol. 7, Iss. 2, pp. 69-73
Open Access | Times Cited: 1
Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
С. К. Груздев, I. V. Podoprigora, О. А. Гизингер
Authorea (Authorea) (2023)
Open Access
С. К. Груздев, I. V. Podoprigora, О. А. Гизингер
Authorea (Authorea) (2023)
Open Access
The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
K Divya, Parneet Hari, Navjot Kanwar, et al.
Advanced Gut & Microbiome Research (2023) Vol. 2023, pp. 1-15
Open Access
K Divya, Parneet Hari, Navjot Kanwar, et al.
Advanced Gut & Microbiome Research (2023) Vol. 2023, pp. 1-15
Open Access
The role of the intestinal permeability in the progression of nonalcoholic fatty liver disease in obese children
Yu.М. Stepanov, N.Yu. Zavhorodnia, N.O. Zhyhyr
GASTROENTEROLOGY (2022) Vol. 56, Iss. 1, pp. 20-28
Closed Access
Yu.М. Stepanov, N.Yu. Zavhorodnia, N.O. Zhyhyr
GASTROENTEROLOGY (2022) Vol. 56, Iss. 1, pp. 20-28
Closed Access
Exploration of metabolites from gut microbiota against nonalcoholic fatty liver disease: A network pharmacology-based study
Ki‐Kwang Oh, Haripriya Gupta, Byeong Hyun Min, et al.
Research Square (Research Square) (2022)
Open Access
Ki‐Kwang Oh, Haripriya Gupta, Byeong Hyun Min, et al.
Research Square (Research Square) (2022)
Open Access
Exploration of metabolites from gut microbiota against nonalcoholic fatty liver disease: A network pharmacology-based study
Ki‐Kwang Oh, Haripriya Gupta, Byeong Hyun Min, et al.
Research Square (Research Square) (2022)
Open Access
Ki‐Kwang Oh, Haripriya Gupta, Byeong Hyun Min, et al.
Research Square (Research Square) (2022)
Open Access
